Retail entity
Novo Nordisk is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. They are better corroborated than the beat average, carrying 4 original sources each against 3.2 for the same window. The 151-day window averages about 0.1 stories each week.
Last mentioned: Aug 24, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 34 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Novo Nordisk is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. They are better corroborated than the beat average, carrying 4 original sources each against 3.2 for the same window. The 151-day window averages about 0.1 stories each week. Coverage clusters in consumer-trends, which accounts for 1 of those 3, with the remainder spread across 2 other categories. At 7, the average consequence score sits above the same-window beat average of 6.3. Eli Lilly appears in 3 tracked Retail stories published from February 19, 2026 through July 19, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 872 Retail stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Eli Lilly. Shared-story counts are live from our verified record — not editorial picks.
The government’s attempt to compete with pharma’s own direct-to-consumer channels has fallen flat, offering a meager 92 discounts that look more like a boutique pop-up than the promised one-stop-shop for affordable meds.
India's pharmaceutical sector has begun a massive rollout of affordable, generic versions of high-demand weight-loss medications, targeting both domestic and international markets. This influx of low-cost GLP-1 agonists is expected to democratize access to obesity treatments, significantly impacting global retail pharmacy chains and e-commerce health platforms.
Walmart reports fourth-quarter earnings following its historic $1 trillion market capitalization milestone on February 3, 2026. The results mark the first under new CEO John Furner and are expected to highlight the retailer's aggressive transition into a tech-powered omnichannel powerhouse.
Source: Yahoo Finance · Today.rtl
Eli Lilly is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
